Publications by authors named "Elizabeth J Shotton"

Article Synopsis
  • A new process analytical technology system is introduced, combining a lab-scale reactor with a liquid-jet cell for real-time monitoring of complex synthesis processes through X-ray absorption spectroscopy (XAS).
  • The system successfully tracked the preparation of sulfonate-stabilized CaCO particles while analyzing changes in calcium speciation as conditions varied over time.
  • By quantitatively resolving composition changes in the synthesis process, this technology enhances our understanding of how process attributes relate to product quality and performance on a molecular level.
View Article and Find Full Text PDF

It is important to be able to identify the precise position of H-atoms in hydrogen bonding interactions to fully understand the effects on the structure and properties of organic crystals. Using a combination of near-edge X-ray absorption fine structure (NEXAFS) spectroscopy and density functional theory (DFT) quantum chemistry calculations, we demonstrate the sensitivity of core-level X-ray spectroscopy to the precise H-atom position within a donor-proton-acceptor system. Exploiting this sensitivity, we then combine the predictive power of DFT with the experimental NEXAFS, confirming the H-atom position identified using single-crystal X-ray diffraction (XRD) techniques more easily than using other H-atom sensitive techniques, such as neutron diffraction.

View Article and Find Full Text PDF

A detailed understanding of the interactions between drugs and their targets is crucial to develop the best possible therapeutic agents. Structure-based drug design relies on the availability of high-resolution structures obtained primarily through X-ray crystallography. Collecting and analysing quickly a large quantity of structural data is crucial to accelerate drug discovery pipelines.

View Article and Find Full Text PDF

Structure-based drug design has become a key tool for the development of novel drugs. The process involves elucidating the three-dimensional structure of the potential drug molecule bound to the target protein that has been identified as playing a key role in the disease state. Using this three-dimensional information facilitates the process of making improvements to the potential drug molecule by highlighting existing and possible new interactions within the binding site.

View Article and Find Full Text PDF

Heterobimetallic complexes of a vanadium(V) and rhenium(VII) combination connected by a mu-oxido bridge [LVO(mu-O)ReO 3].H 2O [H 2L = N, N'-ethylene bis(salicylideneimine) (H 2salen) and its methoxy derivative] ( 1, 2) are reported. The compounds have been prepared by a single-pot synthesis in which the precursor [V (IV)OL] complexes are allowed to be oxidized aerially in the presence of added perrhenate.

View Article and Find Full Text PDF

The polydentate ligand 2,4,6-tris(dipyridin-2-ylamino)-1,3,5-triazine (dpyatriz) in combination with the Cu(ClO 4) 2/CuX 2 salt mixtures (X (-) = Cl (-), Br (-), or N 3 (-)) leads to the formation of molecular coordination aggregates with formulas [Cu 3Cl 3(dpyatriz) 2](ClO 4) 3 ( 2), [Cu 3Br 3(dpyatriz) 2](ClO 4) 3 ( 3), and [Cu 4(N 3) 4(dpyatriz) 2(DMF) 4(ClO 4) 2](ClO 4) 2 ( 4). These complexes consist of two dpyatriz ligands bridged via coordination to Cu (II) and disposed either face-to-face in an eclipsed manner ( 2 and 3) or parallel and mutually shifted in one direction. The copper ions complete their coordination positions with Cl (-) ( 2), Br (-) ( 3), or N 3 (-), ClO 4 (-), and N, N-dimethylformamide (DMF) ( 4) ligands.

View Article and Find Full Text PDF